@ARTICLE{
author={Bar-Or Amit|,Oh J|,Dufek Michal|,Budincevic Hrvoje|,Habek Mario|,Caunt Maresa|,Harp C|,Sierzega M|,Clayton David|,Chen Y|,Ratchford JN|,Goodyear Alexandra|,Drulovic Jelena S|0000-0002-4516-3458},
year={2025},
title={Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={2_SUPPL},
pages={244-244},
document_type={Meeting Abstract},
}